| Literature DB >> 36006293 |
Christina Mergenthaler1, Jake D Mathewson1, Abdullah Latif2, Hasan Tahir3, Vincent Meurrens4, Andreas van Werle4, Aamna Rashid3, Muhammad Tariq3, Tanveer Ahmed2, Farah Naureen3, Ente Rood1.
Abstract
Between September 2020 and March 2021, Mercy Corps piloted hybrid digital (CAPI) and paper-based (PAPI) data collection as part of its tuberculosis (TB) active case finding strategy. Data were collected using CAPI and PAPI at 140 TB chest camps in low Internet access areas of Punjab and Khyber Pakhtunkhwa provinces in Pakistan. PAPI data collection was performed primarily during the camp and entered using a tailor-performed CAPI tool after camps. To assess the feasibility of this hybrid approach, quality of digital records were measured against the paper "gold standard", and user acceptance was evaluated through focus group discussions. Completeness of digital data varied by indicator, van screening team, and month of implementation: chest camp attendees and pulmonary TB cases showed the highest CAPI/PAPI completeness ratios (1.01 and 0.96 respectively), and among them, all forms of TB diagnosis and treatment initiation were lowest (0.63 and 0.64 respectively). Vans entering CAPI data with high levels of completeness generally did so for all indicators, and significant differences in mean indicator completeness rates between PAPI and CAPI were observed between vans. User feedback suggested that although the CAPI tool required practice to gain proficiency, the technology was appreciated and will be better perceived once double entry in CAPI and PAPI can transition to CAPI only. CAPI data collection enables data to be entered in a more timely fashion in low-Internet-access settings, which will enable more rapid, evidence-based program steering. The current system in which double data entry is conducted to ensure data quality is an added burden for staff with many activities. Transitioning to a fully digital data collection system for TB case finding in low-Internet-access settings requires substantial investments in M&E support, shifts in data reporting accountability, and technology to link records of patients who pass through separate data collection stages during chest camp events.Entities:
Keywords: CAPI; PAPI; active case finding; data quality; digital tools; tuberculosis
Year: 2022 PMID: 36006293 PMCID: PMC9415978 DOI: 10.3390/tropicalmed7080201
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Figure 1Intervention Area for Hybrid CAPI/PAPI Data Collection in Chest Camps, Pakistan (September 2020–March 2021).
Individual-level data captured in both PAPI and CAPI tools aggregated to chest camp level for quantitative analysis.
| Individual Level Data (i.e., Chest Camp Indicators) | Data Description |
|---|---|
| Personal identifiers | Name, date of birth, sex, village, contact information |
| Presence of symptoms | Cough, cough duration, hemoptysis, fever, night sweats, unintended weight loss, chest pain |
| TB history or TB contacts | Any TB history or close contacts with TB |
| Chest X-ray type | Analog or digital chest X-ray |
| Chest X-ray result | Normal or abnormal |
| Sputum specimen collected | Yes/No and if yes, specimen type |
| Type of laboratory test administered | Microscopy or polymerase chain reaction (PCR) |
| Laboratory test result | Presence of bacteriological confirmation and rifampicin resistance if PCR used |
| Final diagnosis made | Pulmonary bacteriologically positive (B+) TB/extra pulmonary TB/No TB |
Figure 2Chest camp intervention logic and flow of participants and data.
Completeness of CAPI records per TB active case finding process indicator.
| CAPI Completeness Ratio (CAPI/PAPI) | ||||
|---|---|---|---|---|
|
| ||||
|
|
|
|
|
|
| Chest camp events | ||||
| Chest camp attendees | 1.01 | 1.00 | 0.90 | 1.12 |
| People verbally screened for TB | 0.71 * | 0.98 | 0.46 | 0.96 |
| People receiving CXR | 0.83 * | 1.00 | 0.68 | 0.97 |
| People with abnormal CXR | 0.92 | 1.00 | 0.21 | 1.64 |
| People presumptive for TB (based on 1 or more: CXR, symptoms, TB history) | 2.35 * | 1.11 | 1.30 | 3.41 |
| People lab tested for TB (microscopy or GeneXpert) | 0.72 | 0.91 | 0.26 | 1.18 |
| People diagnosed with B+ TB | 0.96 | 0.00 | 0.32 | 1.61 |
| People diagnosed with AFTB | 0.63 * | 1.00 | 0.29 | 0.97 |
| AFTB patients initiated on TB treatment | 0.64 * | 1.00 | 0.29 | 0.99 |
* p < 0.05.
Figure 3Median and interquartile ranges of mean differences between PAPI and CAPI chest camp indicators. * Significant difference (p < 0.05) in mean values reported between PAPI and CAPI.
Figure 4Consistency of CAPI and PAPI indicators Per van (PAPI-CAPI). (a) People verbally screened; (b) people receiving chest X-ray; (c) people identified with presumptive TB. * Significant difference (p < 0.05) in mean values reported between PAPI and CAPI.
Figure 5Proportion of CAPI chest camps reporting 100% of data correctly based on PAPI data, per indicator by month.